SlideShare a Scribd company logo
D E P T. O F M E D I C I N E ,
B H A R AT I H O S PI TA L A N D R E S E A RC H C E N T R E ,
PU N E .
Role of Family Physician in the
control of chronic kidney
disease(CKD).
Problem statement.
 India is moving ahead in all fronts, especially in the
field of healthcare and in particular medicine.
 The last few decades have seen an increasing number
of infections get under control.
 There is however an increase in the number of non-
communicable diseases like DM, HTN,
Cardiovascular diseases, strokes to name a few. All of
these are eventually associated with co-morbiditiies
such as CKD.
 Data suggests that around 11-15% of the general
population has CKD.
The Problem!!!
Contributors to the problem
 Awareness of kidney diseases is relatively low in our
community including among us doctors and
healthcare workers.
 Sr. Creatinine level, though widely advised and easily
available, is a poor marker of renal function.
 Most patients are asymptomatic to begin with. This
is why they do not approach a doctor in the early
stages of the disease.
What is Chronic Kidney Disease(CKD)?
 CKD is an all inclusive term:
 The chief criteria are:
 Glomerular filtration rate(GFR) < 60 ml/min for >
months.
 Complains of persistent renal damage by pathological or
imaging tests even in presence of a normal GFR.
Why is it CKD and not Chronic Renal Failure (CRF)?
 The spectrum of the patient’s condition ranges from
being asymptomatic to being dialysis dependent.
 The term “kidney” is better understood by the lay
people.
 As mentioned earlier, Sr. Creatinine is not a reliable
marker for assessing renal function; particularly in
the elderly.
 The gold standard test for this purpose remains GFR.
GFR: The Gold Standard.
 Defintion:A kidney function test in which results are
determined from the amount of ultrafiltrate formed by
plasma flowing through the glomeruli of the kidney. The
amount is calculated from inulin and creatinine clearance,
serum creatinine, and blood urea nitrogen.
 A number of formulae have been developed for GFR
estimation. These include.
 Cockcroft-Gault formula.
 Schwartz formula
 Mayo Quadratic formula
 CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula
 Modification of Diet in Renal Disease (MDRD) formula
 The most commonly employed formula is the Cockcroft-
Gault formula:
 A commonly used surrogate marker for estimate of creatinine
clearance (eCCr) is the Cockcroft-Gault formula, which in turn
estimates GFR in ml/min.
(eCCr :- Estimated creatinine clearance rate)
Evolution of CKD
 The disease progresses through 5 stages with
progressive decline in renal function as assessed by
GFR. Out of these:
 Stages 1 and 2 are asymptomatic.
 Stages 3 to 5 correspond to CRF ( GFR < 60 ml/min)
 Stage 5 is also known as End Stage Renal Disease(ESRD)
where the GFR falls to below < 15 ml/min.
 At ESRD the treatment modalities available to the patient
include DIALYSIS or RENAL TRANSPLANT.
Identifying the vunerable population.
 Regular screening for renal function must be done
especially for the subset of population which is at
risk. This includes:
 Elderly people, diabetics, hypertensives.
 Those with malignancy, autoimmune disease.
 Renal stones
 Recurrent UTI, family H/O CKD
 Low birth weight, reduced kidney mass
 Obese people, smokers.
 Users of Non Steroidal Anti-inflammatory Drugs(NSAIDs).
 Young hypertensives.
Role of the Doctor
 A nephrologist has a rather limited role in the early
diagnosis of CKD.
 A family physician is more substantial in the initial
stages. He should develop a high suspicion index for
renal disorders amongst his patients and look for
decline of renal function. He can do this by:
 Looking for protienuria atleast annually
 Sr. Creatinine
 USG (A+P)- for stones, cysts, hydronephrosis.
Advice on Lifestyle modification
 Pt. should target an ideal body weight, exercise
regularly, stop smoking, reduce stress.
 Diet: diet rich in fruits and vegetables are best for
health in presence of normal renal function.
 In CKD stages 3 to 5 however these can be dangerous as they
increase Sr. Potassium. This can be overcome by leaching of
the vegetable.
 Curtail salt intake to 3-4 gm/day.
 Intake-output must be monitored
 Proteins 0.69gm/kg of high biological value.
Routine chek up for all.
 Check up for even the healthy population must be
advocated.
 Every adult must have atleast a Blood Pressure
check annually.
 Out of this the at risk population must be identified
and screened.
Lab tests:
 Urine examination:
 Routine:Simple dipstick for proteinuria in the clinic
 Ideal: the Micral test to look for Microalbuminuria particularly
in the diabetic pateint.
 Microscopy: casts, RBC’s.
• GFR calculation (using Sr. Creatinine)
DM and HTN: Main constituents of the pool.
 Optimal control of BSL:
 Diabetics form 40% of dialysis patients.
 HbA1c < 7% must be targeted in this population.
 Blood pressure control : <130/80 mm of Hg
 Use the combination of correct drugs
 Correct usage of renoprotective agents like ACE Inhibitors and
ARB’s
 Monitoring RFT’s and Sr. Electrolytes while giving these
agents.
Avoiding the pitfalls:
 Advise regarding avoidance of usage of NSAIDs on a
long term basis even for chronic inflammatory
conditions.
 COX -2 Inhibitors
 Treatment of co-morbidities should be thorough.
Since the Risk of coronary events and strokes increases drugs
such as Statins and low dose aspirin should be prescribed as
needed.
Interaction between the physician and the nephrologist.
 An early referral should be done when the creatinine
level is borderline for establishing the etiology and
for treating a correctable cause.
 Patient should follow up with the family physician
regularly.
 Parameters such as BP and haemoglobin levels
(between 11-12 g/dl) should be monitored.
 Avoidance of nephrotoxic drugs.
 Regular monitoring of renal and other parameters
initially- 3 monthly.
 Transplant and dialysis education.
Take Home Message
 India is increasingly becoming renowned as the
Chronic Kidney Disease and Diabetic Capital
 An integrated approach in addition to increased
patient awareness through education can help tame
this modern epidemic.
THANK YOU.

More Related Content

What's hot

Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
Christos Argyropoulos
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy managementNaresh Monigari
 
Management of Diabetes in Hemodialysis Patients
Management of Diabetes in Hemodialysis PatientsManagement of Diabetes in Hemodialysis Patients
Management of Diabetes in Hemodialysis Patients
MNDU net
 
Ckd in kenya
Ckd  in  kenyaCkd  in  kenya
Ckd in kenya
MohamedKhamis77
 
Dilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKDDilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKD
drsanjaymaitra
 
3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)KidneyOrgRu
 
Early detection of diabetic nephropathy
Early detection of diabetic nephropathyEarly detection of diabetic nephropathy
Early detection of diabetic nephropathy
bausher willayat
 
Ckd dr. shanjida
Ckd dr. shanjidaCkd dr. shanjida
Ckd dr. shanjida
Ferdous Rafy
 
Diabetic nephropathy why and why not
Diabetic nephropathy why and why notDiabetic nephropathy why and why not
Diabetic nephropathy why and why not
alaa wafa
 
Hypertension in Chronic Kidney Disease
Hypertension in Chronic Kidney DiseaseHypertension in Chronic Kidney Disease
Hypertension in Chronic Kidney Disease
Ade Wijaya
 
10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis
MNDU net
 
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHYDIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY
Paa Kwesi Hackman
 
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
Dr. Om J Lakhani
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
NephroTube - Dr.Gawad
 
Protecting the Kidney in Diabetes
Protecting the Kidney in DiabetesProtecting the Kidney in Diabetes
Protecting the Kidney in Diabetes
Iris Thiele Isip-Tan
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Disease
drsanjaymaitra
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
Prateek Singh
 
Post Transplant Diabetes Mellitus
Post Transplant Diabetes MellitusPost Transplant Diabetes Mellitus
Post Transplant Diabetes Mellitus
Dr Karthik Balachandran
 

What's hot (20)

Diabetic kidney disease 2021
Diabetic kidney disease 2021 Diabetic kidney disease 2021
Diabetic kidney disease 2021
 
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy management
 
Dkd
DkdDkd
Dkd
 
Management of Diabetes in Hemodialysis Patients
Management of Diabetes in Hemodialysis PatientsManagement of Diabetes in Hemodialysis Patients
Management of Diabetes in Hemodialysis Patients
 
Ckd in kenya
Ckd  in  kenyaCkd  in  kenya
Ckd in kenya
 
Dilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKDDilemma of Treating Diabetes in CKD
Dilemma of Treating Diabetes in CKD
 
3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)3-2. Hypertension in CKD. Francesco Emma (eng)
3-2. Hypertension in CKD. Francesco Emma (eng)
 
Early detection of diabetic nephropathy
Early detection of diabetic nephropathyEarly detection of diabetic nephropathy
Early detection of diabetic nephropathy
 
Ckd dr. shanjida
Ckd dr. shanjidaCkd dr. shanjida
Ckd dr. shanjida
 
Diabetic nephropathy why and why not
Diabetic nephropathy why and why notDiabetic nephropathy why and why not
Diabetic nephropathy why and why not
 
Hypertension in Chronic Kidney Disease
Hypertension in Chronic Kidney DiseaseHypertension in Chronic Kidney Disease
Hypertension in Chronic Kidney Disease
 
10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis10 TIPS to Approach a Pregnant lady on Hemodialysis
10 TIPS to Approach a Pregnant lady on Hemodialysis
 
DIABETIC NEPHROPATHY
DIABETIC NEPHROPATHYDIABETIC NEPHROPATHY
DIABETIC NEPHROPATHY
 
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
MANAGEMENT OF DIABETES IN CHRONIC KIDNEY DISEASE (Special reference to Use of...
 
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. GawadChallenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
Challenges in Diagnosis and Management of Diabetic Kidney Disease - Dr. Gawad
 
Protecting the Kidney in Diabetes
Protecting the Kidney in DiabetesProtecting the Kidney in Diabetes
Protecting the Kidney in Diabetes
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Disease
 
Diabetic nephropathy
Diabetic nephropathyDiabetic nephropathy
Diabetic nephropathy
 
Post Transplant Diabetes Mellitus
Post Transplant Diabetes MellitusPost Transplant Diabetes Mellitus
Post Transplant Diabetes Mellitus
 

Similar to Ckd and the family physician

Diabetic Kidney Disease.pptx
Diabetic Kidney Disease.pptxDiabetic Kidney Disease.pptx
Diabetic Kidney Disease.pptx
TanvirMahmud53
 
Pcp in a box module 1
Pcp in a box   module 1Pcp in a box   module 1
Pcp in a box module 1
MohibaAgha
 
injuria renal 4.pptx
injuria renal 4.pptxinjuria renal 4.pptx
injuria renal 4.pptx
MartyMcfly25
 
CKD Dr. Shanjida
CKD Dr. ShanjidaCKD Dr. Shanjida
CKD Dr. Shanjida
Ferdous101531
 
Ckd 2016 100 2
Ckd 2016 100 2Ckd 2016 100 2
Ckd 2016 100 2
FarragBahbah
 
Complications of type 2 Diabetes mellitus
Complications of type 2 Diabetes mellitusComplications of type 2 Diabetes mellitus
Complications of type 2 Diabetes mellitusDebajyoti Chakraborty
 
Approach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptxApproach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptx
imrulsujon1
 
Antiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptxAntiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptx
ParikshitMishra15
 
CKD PPT DOC.pptx
CKD PPT DOC.pptxCKD PPT DOC.pptx
CKD PPT DOC.pptx
LucyMurugara
 
Management of Diabetic Nephropathy
Management of Diabetic NephropathyManagement of Diabetic Nephropathy
Management of Diabetic Nephropathy
drsanjaymaitra
 
Chronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic testsChronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic tests
Dr. Rajesh Bendre
 
CKD Presentation1 2.pptx
CKD Presentation1 2.pptxCKD Presentation1 2.pptx
CKD Presentation1 2.pptx
AnimeshKumar687197
 
CKD and Diabetes: Tips & Tricks
CKD and Diabetes: Tips & TricksCKD and Diabetes: Tips & Tricks
CKD and Diabetes: Tips & Tricks
Usama Ragab
 
Renal impairment and anaesthesia
Renal impairment and anaesthesiaRenal impairment and anaesthesia
Renal impairment and anaesthesia
Errol Williamson
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Disease
drsanjaymaitra
 
Ueda 2016 7-diabetic complications - adel el sayed
Ueda 2016 7-diabetic complications -  adel el sayedUeda 2016 7-diabetic complications -  adel el sayed
Ueda 2016 7-diabetic complications - adel el sayed
ueda2015
 
Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD)Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD)
Tsegaye Melaku
 
Ckd prevention
Ckd preventionCkd prevention
Ckd prevention
darsh 1980
 

Similar to Ckd and the family physician (20)

Diabetic Kidney Disease.pptx
Diabetic Kidney Disease.pptxDiabetic Kidney Disease.pptx
Diabetic Kidney Disease.pptx
 
Pcp in a box module 1
Pcp in a box   module 1Pcp in a box   module 1
Pcp in a box module 1
 
injuria renal 4.pptx
injuria renal 4.pptxinjuria renal 4.pptx
injuria renal 4.pptx
 
CKD Dr. Shanjida
CKD Dr. ShanjidaCKD Dr. Shanjida
CKD Dr. Shanjida
 
Ckd 2016 100 2
Ckd 2016 100 2Ckd 2016 100 2
Ckd 2016 100 2
 
Complications of type 2 Diabetes mellitus
Complications of type 2 Diabetes mellitusComplications of type 2 Diabetes mellitus
Complications of type 2 Diabetes mellitus
 
Approach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptxApproach To CKD Patient....................pptx.pptx
Approach To CKD Patient....................pptx.pptx
 
final.pptx
final.pptxfinal.pptx
final.pptx
 
Antiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptxAntiprotenuric Antihypertensives.pptx
Antiprotenuric Antihypertensives.pptx
 
CKD PPT DOC.pptx
CKD PPT DOC.pptxCKD PPT DOC.pptx
CKD PPT DOC.pptx
 
Management of Diabetic Nephropathy
Management of Diabetic NephropathyManagement of Diabetic Nephropathy
Management of Diabetic Nephropathy
 
Chronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic testsChronic renal failure update on diagnostic tests
Chronic renal failure update on diagnostic tests
 
CKD Presentation1 2.pptx
CKD Presentation1 2.pptxCKD Presentation1 2.pptx
CKD Presentation1 2.pptx
 
CKD and Diabetes: Tips & Tricks
CKD and Diabetes: Tips & TricksCKD and Diabetes: Tips & Tricks
CKD and Diabetes: Tips & Tricks
 
Renal impairment and anaesthesia
Renal impairment and anaesthesiaRenal impairment and anaesthesia
Renal impairment and anaesthesia
 
Diabetic Kidney Disease
Diabetic Kidney DiseaseDiabetic Kidney Disease
Diabetic Kidney Disease
 
Ueda 2016 7-diabetic complications - adel el sayed
Ueda 2016 7-diabetic complications -  adel el sayedUeda 2016 7-diabetic complications -  adel el sayed
Ueda 2016 7-diabetic complications - adel el sayed
 
Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD)Chronic Kidney Disease (CKD)
Chronic Kidney Disease (CKD)
 
Diabetic+Nephropathy
Diabetic+NephropathyDiabetic+Nephropathy
Diabetic+Nephropathy
 
Ckd prevention
Ckd preventionCkd prevention
Ckd prevention
 

More from Sachin Adukia

Ophthalmoscopy in 21st century
Ophthalmoscopy in 21st centuryOphthalmoscopy in 21st century
Ophthalmoscopy in 21st century
Sachin Adukia
 
CMB and ICH on oral anticoagulation in strokes due to non valvular AF
CMB and ICH on oral anticoagulation in strokes due to non valvular AFCMB and ICH on oral anticoagulation in strokes due to non valvular AF
CMB and ICH on oral anticoagulation in strokes due to non valvular AF
Sachin Adukia
 
MCI practice update 2018
MCI practice update 2018 MCI practice update 2018
MCI practice update 2018
Sachin Adukia
 
Electrodiagnostic approach to peripheral neuropathy
Electrodiagnostic approach to peripheral neuropathyElectrodiagnostic approach to peripheral neuropathy
Electrodiagnostic approach to peripheral neuropathy
Sachin Adukia
 
Epileptic encephalopathies
Epileptic encephalopathiesEpileptic encephalopathies
Epileptic encephalopathies
Sachin Adukia
 
neurodegeneration due to braiin iron accumulation
neurodegeneration due to braiin iron accumulationneurodegeneration due to braiin iron accumulation
neurodegeneration due to braiin iron accumulation
Sachin Adukia
 
Management of motor neuron disease
Management of motor neuron diseaseManagement of motor neuron disease
Management of motor neuron disease
Sachin Adukia
 
normal eeg
 normal eeg  normal eeg
normal eeg
Sachin Adukia
 
Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
Sachin Adukia
 
PLEDS
PLEDSPLEDS
Parasomnias
ParasomniasParasomnias
Parasomnias
Sachin Adukia
 
Newanti epileptic drugs
Newanti epileptic drugsNewanti epileptic drugs
Newanti epileptic drugs
Sachin Adukia
 
Nerves conduction study
Nerves conduction study Nerves conduction study
Nerves conduction study
Sachin Adukia
 
Imaging based selection of patients for acute stroke treatment
Imaging based selection of patients for acute stroke treatmentImaging based selection of patients for acute stroke treatment
Imaging based selection of patients for acute stroke treatment
Sachin Adukia
 
Primary Headaches
Primary HeadachesPrimary Headaches
Primary Headaches
Sachin Adukia
 
Autoimmune encephalitis ppt
Autoimmune encephalitis pptAutoimmune encephalitis ppt
Autoimmune encephalitis ppt
Sachin Adukia
 
Approach to stupor and coma
Approach to stupor and comaApproach to stupor and coma
Approach to stupor and coma
Sachin Adukia
 
simultaneous anterolateral medullary infarct
 simultaneous anterolateral medullary infarct  simultaneous anterolateral medullary infarct
simultaneous anterolateral medullary infarct
Sachin Adukia
 
multiple level spondylodiscitis in neurobrucllosis: int jr of medicine
multiple level spondylodiscitis in neurobrucllosis:  int jr of medicinemultiple level spondylodiscitis in neurobrucllosis:  int jr of medicine
multiple level spondylodiscitis in neurobrucllosis: int jr of medicine
Sachin Adukia
 
hypertrophic pachymeningitis
hypertrophic pachymeningitishypertrophic pachymeningitis
hypertrophic pachymeningitis
Sachin Adukia
 

More from Sachin Adukia (20)

Ophthalmoscopy in 21st century
Ophthalmoscopy in 21st centuryOphthalmoscopy in 21st century
Ophthalmoscopy in 21st century
 
CMB and ICH on oral anticoagulation in strokes due to non valvular AF
CMB and ICH on oral anticoagulation in strokes due to non valvular AFCMB and ICH on oral anticoagulation in strokes due to non valvular AF
CMB and ICH on oral anticoagulation in strokes due to non valvular AF
 
MCI practice update 2018
MCI practice update 2018 MCI practice update 2018
MCI practice update 2018
 
Electrodiagnostic approach to peripheral neuropathy
Electrodiagnostic approach to peripheral neuropathyElectrodiagnostic approach to peripheral neuropathy
Electrodiagnostic approach to peripheral neuropathy
 
Epileptic encephalopathies
Epileptic encephalopathiesEpileptic encephalopathies
Epileptic encephalopathies
 
neurodegeneration due to braiin iron accumulation
neurodegeneration due to braiin iron accumulationneurodegeneration due to braiin iron accumulation
neurodegeneration due to braiin iron accumulation
 
Management of motor neuron disease
Management of motor neuron diseaseManagement of motor neuron disease
Management of motor neuron disease
 
normal eeg
 normal eeg  normal eeg
normal eeg
 
Progressive myoclonic epilepsy
Progressive myoclonic epilepsyProgressive myoclonic epilepsy
Progressive myoclonic epilepsy
 
PLEDS
PLEDSPLEDS
PLEDS
 
Parasomnias
ParasomniasParasomnias
Parasomnias
 
Newanti epileptic drugs
Newanti epileptic drugsNewanti epileptic drugs
Newanti epileptic drugs
 
Nerves conduction study
Nerves conduction study Nerves conduction study
Nerves conduction study
 
Imaging based selection of patients for acute stroke treatment
Imaging based selection of patients for acute stroke treatmentImaging based selection of patients for acute stroke treatment
Imaging based selection of patients for acute stroke treatment
 
Primary Headaches
Primary HeadachesPrimary Headaches
Primary Headaches
 
Autoimmune encephalitis ppt
Autoimmune encephalitis pptAutoimmune encephalitis ppt
Autoimmune encephalitis ppt
 
Approach to stupor and coma
Approach to stupor and comaApproach to stupor and coma
Approach to stupor and coma
 
simultaneous anterolateral medullary infarct
 simultaneous anterolateral medullary infarct  simultaneous anterolateral medullary infarct
simultaneous anterolateral medullary infarct
 
multiple level spondylodiscitis in neurobrucllosis: int jr of medicine
multiple level spondylodiscitis in neurobrucllosis:  int jr of medicinemultiple level spondylodiscitis in neurobrucllosis:  int jr of medicine
multiple level spondylodiscitis in neurobrucllosis: int jr of medicine
 
hypertrophic pachymeningitis
hypertrophic pachymeningitishypertrophic pachymeningitis
hypertrophic pachymeningitis
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Ckd and the family physician

  • 1. D E P T. O F M E D I C I N E , B H A R AT I H O S PI TA L A N D R E S E A RC H C E N T R E , PU N E . Role of Family Physician in the control of chronic kidney disease(CKD).
  • 2. Problem statement.  India is moving ahead in all fronts, especially in the field of healthcare and in particular medicine.  The last few decades have seen an increasing number of infections get under control.  There is however an increase in the number of non- communicable diseases like DM, HTN, Cardiovascular diseases, strokes to name a few. All of these are eventually associated with co-morbiditiies such as CKD.  Data suggests that around 11-15% of the general population has CKD.
  • 4. Contributors to the problem  Awareness of kidney diseases is relatively low in our community including among us doctors and healthcare workers.  Sr. Creatinine level, though widely advised and easily available, is a poor marker of renal function.  Most patients are asymptomatic to begin with. This is why they do not approach a doctor in the early stages of the disease.
  • 5. What is Chronic Kidney Disease(CKD)?  CKD is an all inclusive term:  The chief criteria are:  Glomerular filtration rate(GFR) < 60 ml/min for > months.  Complains of persistent renal damage by pathological or imaging tests even in presence of a normal GFR.
  • 6. Why is it CKD and not Chronic Renal Failure (CRF)?  The spectrum of the patient’s condition ranges from being asymptomatic to being dialysis dependent.  The term “kidney” is better understood by the lay people.  As mentioned earlier, Sr. Creatinine is not a reliable marker for assessing renal function; particularly in the elderly.  The gold standard test for this purpose remains GFR.
  • 7. GFR: The Gold Standard.  Defintion:A kidney function test in which results are determined from the amount of ultrafiltrate formed by plasma flowing through the glomeruli of the kidney. The amount is calculated from inulin and creatinine clearance, serum creatinine, and blood urea nitrogen.  A number of formulae have been developed for GFR estimation. These include.  Cockcroft-Gault formula.  Schwartz formula  Mayo Quadratic formula  CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula  Modification of Diet in Renal Disease (MDRD) formula
  • 8.  The most commonly employed formula is the Cockcroft- Gault formula:  A commonly used surrogate marker for estimate of creatinine clearance (eCCr) is the Cockcroft-Gault formula, which in turn estimates GFR in ml/min. (eCCr :- Estimated creatinine clearance rate)
  • 9. Evolution of CKD  The disease progresses through 5 stages with progressive decline in renal function as assessed by GFR. Out of these:  Stages 1 and 2 are asymptomatic.  Stages 3 to 5 correspond to CRF ( GFR < 60 ml/min)  Stage 5 is also known as End Stage Renal Disease(ESRD) where the GFR falls to below < 15 ml/min.  At ESRD the treatment modalities available to the patient include DIALYSIS or RENAL TRANSPLANT.
  • 10. Identifying the vunerable population.  Regular screening for renal function must be done especially for the subset of population which is at risk. This includes:  Elderly people, diabetics, hypertensives.  Those with malignancy, autoimmune disease.  Renal stones  Recurrent UTI, family H/O CKD  Low birth weight, reduced kidney mass  Obese people, smokers.  Users of Non Steroidal Anti-inflammatory Drugs(NSAIDs).  Young hypertensives.
  • 11. Role of the Doctor  A nephrologist has a rather limited role in the early diagnosis of CKD.  A family physician is more substantial in the initial stages. He should develop a high suspicion index for renal disorders amongst his patients and look for decline of renal function. He can do this by:  Looking for protienuria atleast annually  Sr. Creatinine  USG (A+P)- for stones, cysts, hydronephrosis.
  • 12. Advice on Lifestyle modification  Pt. should target an ideal body weight, exercise regularly, stop smoking, reduce stress.  Diet: diet rich in fruits and vegetables are best for health in presence of normal renal function.  In CKD stages 3 to 5 however these can be dangerous as they increase Sr. Potassium. This can be overcome by leaching of the vegetable.  Curtail salt intake to 3-4 gm/day.  Intake-output must be monitored  Proteins 0.69gm/kg of high biological value.
  • 13. Routine chek up for all.  Check up for even the healthy population must be advocated.  Every adult must have atleast a Blood Pressure check annually.  Out of this the at risk population must be identified and screened.
  • 14. Lab tests:  Urine examination:  Routine:Simple dipstick for proteinuria in the clinic  Ideal: the Micral test to look for Microalbuminuria particularly in the diabetic pateint.  Microscopy: casts, RBC’s. • GFR calculation (using Sr. Creatinine)
  • 15. DM and HTN: Main constituents of the pool.  Optimal control of BSL:  Diabetics form 40% of dialysis patients.  HbA1c < 7% must be targeted in this population.  Blood pressure control : <130/80 mm of Hg  Use the combination of correct drugs  Correct usage of renoprotective agents like ACE Inhibitors and ARB’s  Monitoring RFT’s and Sr. Electrolytes while giving these agents.
  • 16. Avoiding the pitfalls:  Advise regarding avoidance of usage of NSAIDs on a long term basis even for chronic inflammatory conditions.  COX -2 Inhibitors  Treatment of co-morbidities should be thorough. Since the Risk of coronary events and strokes increases drugs such as Statins and low dose aspirin should be prescribed as needed.
  • 17. Interaction between the physician and the nephrologist.  An early referral should be done when the creatinine level is borderline for establishing the etiology and for treating a correctable cause.  Patient should follow up with the family physician regularly.  Parameters such as BP and haemoglobin levels (between 11-12 g/dl) should be monitored.  Avoidance of nephrotoxic drugs.  Regular monitoring of renal and other parameters initially- 3 monthly.  Transplant and dialysis education.
  • 18. Take Home Message  India is increasingly becoming renowned as the Chronic Kidney Disease and Diabetic Capital  An integrated approach in addition to increased patient awareness through education can help tame this modern epidemic.